C&G Editor in Chief, Erin Harris

  1. Vor Bio Shares Progress For Patients with AML 11/17/2023

    I talked to Dr. Robert Ang, President and Chief Executive Officer at Vor Bio about the company's VBP101 study for trem-cel in patients with acute myeloid leukemia (AML)

  2. The Eye: A Candidate For Modifier Gene Therapy 11/17/2023

    Ocugen's Chairman, CEO and Co-founder, Shankar Musunuri ,Ph.D., MBA, provides an update on OCU400 and other ongoing trials, why the eye is a good target for gene therapy, the outlook for retinal gene therapy, and more.

  3. Video Clips From Cell & Gene Live: Regulating The CGT Workflow To Improve Patient Safety 10/31/2023

    Here is a breakdown of original 60-minute Cell & Gene Live, Regulating the CGT Workflow to Improve Patient Safety, into video segments by topic.

  4. A Sneak Peek At REGENXBIO On Cell & Gene: The Podcast 10/30/2023

    REGENXBIO's CEO, President, and Director, Ken Mills and I sat down to record an upcoming episode of Cell & Gene: The Podcast. Here's a sneak peak of the episode.

  5. Highlights from In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg 10/27/2023

    Umoja Biopharma’s Dr. Andrew Scharenberg joined me as my guest on a recent episode of Cell & Gene: The Podcast to discuss the evolution of in vivo CAR-T cell therapeutics. Here are highlights from our conversation. 

  6. ARM's 2023 Meeting On The Mesa: Data, Ethics, And More 10/19/2023

    ARM's 2023 Meeting on the Mesa was chock full of informative sessions, impactful conversations, partnering opportunities, and peer networking. Here's a brief recap.

  7. September's Top Content On Cell & Gene 9/29/2023

    Here is a glimpse of the impactful content, in various formats, Cell & Gene delivered this month.

  8. Dr. Jim Wilson At LSPA's Life Sciences Future Conference 9/28/2023

    LSPA's Life Science Future event included a plenary session featuring Jim Wilson Ph.D., M.D., Director, Gene Therapy Program Professor of Medicine and Pediatrics, Perelman School of Medicine at the University of Pennsylvania. Here's a recap of that session.

  9. CBER's Dr. Peter Marks, ARM's Mike Lehmicke On Genome Editing Technologies 9/19/2023

    Recent conversations with some of the industry's top experts show genome editing technologies are here to stay and evolving rapidly.

  10. Regulating the CGT Workflow To Improve Patient Safety 8/31/2023

    In case you missed it, our most recent Cell & Gene Live, Regulating the CGT Workflow To Improve Patient Safety, featuring expert panelists Nimi Chhina, Ph.D., J.D. Executive Director, Head of Global R&D and Regulatory Policy Global Regulatory Affairs, Worldwide Research & Development at BioMarin Pharmaceutical, and Bob Pietrusko, Pharm.D., Chief Regulatory & Quality Officer at Vor Biopharma, is available on demand in its entirety.